Back to VA VANGUARD CAPITAL MANAGEMENT LLC
MNPR2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in MONOPAR THERAPEUTICS INC
Yes. Vanguard Capital Management holds 209,711 shares of MNPR (Monopar Therapeutics), worth $19.4M, as of its Q2 2026 13F filing. It reduced the position by 8,752 shares (-4.0%) from Q1 2026. Vanguard Capital Management has held MNPR in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$19.4M
Current Shares
209,711
Total Value Change
+$7.4M
Total Shares Change
-8,752
Quarter-by-Quarter History
Other major holders of MNPR: Jupiter Topco LLC, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.